Literature DB >> 29115115

LATENT TUBERCULOSIS AMONG ADULT ETHIOPIAN PATIENTSzzm321990AT CHEST CLINIC, TIKURANBESSA SPECIALIZED HOSPITAL,zzm321990ADDIS ABABA, ETHIOPIA.

Amsalu Bekele, Senait Ashenafi, Getachew Aderay, Getachew Assefa, Abraham Aseffa, Jan Anderssen, Susanna Brighenti.   

Abstract

Background: One-third of the world population is infected with Mycobacterium tuberculosis. Most people exposed to M. tuberculosis showed no evidence of active disease. About 5-10% of people with latent tuberculosis infection (LTBI) without HIV will progress to develop active tuberculosis (TB) in their lifetimes. This study was conducted to determine the magnitude of latent TB among the adult population at a teaching and referral Hospital in Ethiopia.
Methods: This study was conducted at the Chest clinic of Tikur Anbessa Specialized Hospital during 2010-2013. The study was a cross-sectional study conducted among healthy adults after informed consent was obtained from each individual. Tuberculin skin test (TST) and Interferon Gamma whole blood assay (Quantiferon-Tuberculosis- Gold) was performed using enzyme linked immuno-sorbent assay. Average CD4, CD8, CD3 and CD4:CD8 ratio was determined for all study participants.
Results: From a total of 70 healthy adults tested for LTBI using Quantiferon Gold, 45(64%) tested positive and 25 (36%) were negative for latent tuberculosis infection. From the 66 healthy individuals who were tested using TST for LTBI, 42 (62%) individuals were TST positive and 25 (38%) individuals were TST negative. Average CD4, CD8, CD3 and CD4:CD8 ratio was 748, 598, 1401 and 1.4, respectively. Conclusions: The magnitude of latent tuberculosis infection was high in this study, which reflects existing high prevalence of TB. TST and Quantiferon-Tuberculosis-Gold assay show similar efficacy for the diagnosis of LTBI in healthy Ethiopian adults. The absolute CD4 T-cell counts of healthy HIV- negative Ethiopians are considerably lower than CD4 T cell counts in other countries.

Entities:  

Mesh:

Year:  2016        PMID: 29115115

Source DB:  PubMed          Journal:  Ethiop Med J        ISSN: 0014-1755


  3 in total

1.  Interferon Gamma Release Assay and Tuberculin Skin Test Performance in Pregnant Women Living With and Without HIV.

Authors:  Samantha R Kaplan; Jaclyn N Escudero; Jerphason Mecha; Barbra A Richardson; Elizabeth Maleche-Obimbo; Daniel Matemo; John Kinuthia; Grace C John-Stewart; Sylvia M LaCourse
Journal:  J Acquir Immune Defic Syndr       Date:  2022-01-01       Impact factor: 3.771

2.  Effect of pregnancy and HIV infection on detection of latent TB infection by Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube assay among women living in a high TB and HIV burden setting.

Authors:  Mahlet Birku; Girmay Desalegn; Getachew Kassa; Aster Tsegaye; Markos Abebe
Journal:  Int J Infect Dis       Date:  2020-10-09       Impact factor: 12.074

3.  Does Isoniazid Preventive Therapy Provide Better Treatment Outcomes in HIV-Infected Individuals in Northern Ethiopia? A Retrospective Cohort Study.

Authors:  Tesfay Mehari Atey; Helen Bitew; Solomon Weldegebreal Asgedom; Asrat Endrias; Derbew Fikadu Berhe
Journal:  AIDS Res Treat       Date:  2020-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.